Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Madoz

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Leukemia & Lymphoma|January 1, 1992
High-dose chemotherapy with bone marrow rescue for treatment of Hodgkin's diseaseA Sureda, S Brunet, J J Lopez, et al.
Hepatology (Baltimore, Md.)|August 1, 1995
Efficacy of screening donors for antibodies to the hepatitis C virus to prevent transfusion-associated hepatitis: final report of a prospective trialA González, J I Esteban, P Madoz, et al.
Journal of Viral Hepatitis|January 1, 1995
Comparative study of two high doses of lymphoblastoid interferon in the treatment of chronic hepatitis C: influence on the levels of ALT, viraemia and histologic activityJ Enríquez, X Torras, F Miralles, et al.
Neurology|September 15, 2006
Infusion of platelets transiently reduces nucleoside overload in MNGIEM C Lara, B Weiss, I Illa, et al.
Transplantation Proceedings|August 1, 1995
Peripheral blood stem cell mobilization following salvage chemotherapy (IAPVP-16) plus granulocyte colony-stimulating factor and autografting for non-Hodgkin's lymphomaC Martínez, R Mateu, A Sureda, et al.
Annals of Internal Medicine|September 15, 1991
High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virusJ I Esteban, J C López-Talavera, J Genescà, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 11, 2000
Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin timeJ C Souto, L Almasy, E Muñiz-Diaz, et al.
Revista De Sanidad E Higiene Publica|July 1, 1993
[A Consensus Conference: clinical indications and risks of fresh frozen plasma]M Rutlant Bañeres, R Arrieta Gallastegui, P Farjas Abadía, et al.
Bone Marrow Transplantation|August 5, 2000
Mobilization kinetics of peripheral blood progenitor cells after IAPVP-16 salvage chemotherapy plus G-CSF in lymphoproliferative disordersA Altés, R López, R Martino, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Leukemia & Lymphoma|January 1, 1992
High-dose chemotherapy with bone marrow rescue for treatment of Hodgkin's diseaseA Sureda, S Brunet, J J Lopez, et al.
Hepatology (Baltimore, Md.)|August 1, 1995
Efficacy of screening donors for antibodies to the hepatitis C virus to prevent transfusion-associated hepatitis: final report of a prospective trialA González, J I Esteban, P Madoz, et al.
Journal of Viral Hepatitis|January 1, 1995
Comparative study of two high doses of lymphoblastoid interferon in the treatment of chronic hepatitis C: influence on the levels of ALT, viraemia and histologic activityJ Enríquez, X Torras, F Miralles, et al.
Neurology|September 15, 2006
Infusion of platelets transiently reduces nucleoside overload in MNGIEM C Lara, B Weiss, I Illa, et al.
Transplantation Proceedings|August 1, 1995
Peripheral blood stem cell mobilization following salvage chemotherapy (IAPVP-16) plus granulocyte colony-stimulating factor and autografting for non-Hodgkin's lymphomaC Martínez, R Mateu, A Sureda, et al.
Annals of Internal Medicine|September 15, 1991
High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virusJ I Esteban, J C López-Talavera, J Genescà, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 11, 2000
Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin timeJ C Souto, L Almasy, E Muñiz-Diaz, et al.
Revista De Sanidad E Higiene Publica|July 1, 1993
[A Consensus Conference: clinical indications and risks of fresh frozen plasma]M Rutlant Bañeres, R Arrieta Gallastegui, P Farjas Abadía, et al.
Bone Marrow Transplantation|August 5, 2000
Mobilization kinetics of peripheral blood progenitor cells after IAPVP-16 salvage chemotherapy plus G-CSF in lymphoproliferative disordersA Altés, R López, R Martino, et al.
Pageof 6